Thanks to in-utero blood transfusion technology, what was once a fatal diagnosis in the womb can now result in live births.

Nineteen candles lit up the cake for Caden Major this year, but the true celebration was something he once thought impossible ...

Capsida has yet to disclose the exact cause of death. The patient had received the gene therapy CAP-002 for a type of ...

Changing Guest on Power Athlete Radio I've had the chance to sit down with some of the most intelligent people in the world here on Power Athlete Radio, ...

Construction has begun on a new centre for gene and cell therapy in the German capital, Berlin. The "Translation Centre" will ...

Capsida Biotherapeutics has paused a gene therapy trial after the first patient died. | Capsida Biotherapeutics has paused a ...

Jesse Gelsinger died after receiving a gene therapy treatment to treat a liver disease. The death sparked an investigation ...

Children with hereditary deafness regained their hearing thanks to a type of gene therapy, a new study published on Wednesday found. In a clinical trial, co-led by investigators from Mass Eye and Ear, ...

University of Iowa researchers developed a gene therapy that could prevent craniosynostosis, a condition where babies’ skull ...

The first participant in an investigational gene therapy trial of STXBP1 encephalopathy died, Capsida Biotherapeutics said.

The biotech has paused its Phase I trial of CAP-002, pending investigation into the “root cause” of the death.